Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Manganese toxicity upon overexposure.

Crossgrove J, Zheng W.

NMR Biomed. 2004 Dec;17(8):544-53. Review.

2.

Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction.

Grant D, Toft KG, Martinsen I, Atzpodien E.

Acta Radiol. 1997 Jul;38(4 Pt 2):732-9.

PMID:
9245969
3.
4.

MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers.

Wang C, Gordon PB, Hustvedt SO, Grant D, Sterud AT, Martinsen I, Ahlström H, Hemmingsson A.

Acta Radiol. 1997 Jul;38(4 Pt 2):665-76.

PMID:
9245962
5.

Cardiac metal contents after infusions of manganese. An experimental evaluation in the isolated rat heart.

Brurok H, Berg K, Sneen L, Grant D, Karlsson JO, Jynge P.

Invest Radiol. 1999 Jul;34(7):470-6.

PMID:
10399637
6.

NMR relaxation studies with MnDPDP.

Southon TE, Grant D, Bjørnerud A, Moen OM, Spilling B, Martinsen I, Refsum H.

Acta Radiol. 1997 Jul;38(4 Pt 2):708-16.

PMID:
9245966
7.

The need for effective contrast agents to enhance the performance of MR imaging.

Grant D, Refsum H, Rummeny E, Marchal G.

Acta Radiol. 1997 Jul;38(4 Pt 2):623-5. No abstract available.

PMID:
9245954
8.

Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2.

Ni Y, Petré C, Bosmans H, Miao Y, Grant D, Baert AL, Marchal G.

Acta Radiol. 1997 Jul;38(4 Pt 2):700-7.

PMID:
9245965
9.

Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration.

Hustvedt SO, Grant D, Southon TE, Zech K.

Acta Radiol. 1997 Jul;38(4 Pt 2):690-9.

PMID:
9245964
10.

General toxicology of MnDPDP.

Larsen LE, Grant D.

Acta Radiol. 1997 Jul;38(4 Pt 2):770-9. Review.

PMID:
9245973
11.

Thallium-like test for myocardial viability with MnDPDP-enhanced MRI.

Wendland MF, Saeed M, Bremerich J, Arheden H, Higgins CB.

Acad Radiol. 2002 May;9 Suppl 1:S82-3. No abstract available.

PMID:
12019904
12.

Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP.

Gallez B, Bacic G, Swartz HM.

Magn Reson Med. 1996 Jan;35(1):14-9.

PMID:
8771018
13.

Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents.

Gallez B, Baudelet C, Adline J, Geurts M, Delzenne N.

Chem Res Toxicol. 1997 Apr;10(4):360-3.

PMID:
9114970
14.

Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR.

Schmidt PP, Toft KG, Skotland T, Andersson K.

J Biol Inorg Chem. 2002 Mar;7(3):241-8. Epub 2001 Oct 19.

PMID:
11935348
15.

Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.

Bernardino ME, Young SW, Lee JK, Weinreb J.

Invest Radiol. 1991 Nov;26 Suppl 1:S148-9; discussion S150-5. No abstract available.

PMID:
1808113
16.
17.

Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.

Padovani B, Lecesne R, Raffaelli C, Chevallier P, Drouillard J, Bruneton JN, Lambrechts M, Gordon P.

Eur J Radiol. 1996 Nov;23(3):205-11.

PMID:
9003926
18.

Relaxation enhancing properties of MnDPDP in human myocardium.

Skjold A, Vangberg TR, Kristoffersen A, Haraldseth O, Jynge P, Larsson HB.

J Magn Reson Imaging. 2004 Dec;20(6):948-52.

PMID:
15558550
19.

Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats.

Treinen KA, Gray TJ, Blazak WF.

Teratology. 1995 Aug;52(2):109-15.

PMID:
8588182
20.

Supplemental Content

Support Center